Our results indicated that breast cancer patients with later pathological stages, more lymph node metastasis, negative hormone receptor expression, and positive HER2 expression tended to have a higher percentage of risk to develop secondary diabetes and IFG. The gene discussed is NR4A1; the disease is diabetes mellitus.